PATENT CLAIM ANALYSIS

Application Number: 16136167
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "093700"]

Abstract:
The invention provides a method for treating a condition in which growth hormone administration is beneficial, for treating osteoarthritis, for increasing chondrocyte, proteoglycan or collagen production or quality or repair or promoting cartilage tissue formation or repair, for promoting or improving muscle, ligament or tendon mass, repair, form or function, or for treating inflammatory, traumatic or genetic diseases of muscle or connective tissue, comprising administering to a subject an effective amount of a peptide comprising a carboxyl-terminal sequence from a growth hormone and not the IGF-1 domain of growth hormone. It also provides a method of treating a condition involving insufficient functional chondrocytes or insufficient functional cartilage tissue, the method comprising administering to a subject in need thereof a peptide comprising a carboxyl-terminal sequence from a growth hormone and not the domain of growth hormone responsible for IGF-1 production.

Claim (Index 17):
The method of  claim 20 , wherein the peptide comprises amino acids 177-191 of human growth hormone.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 2.23529
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14363256', '14293851', '10740098', '11579124', '13466672']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7312916737524361
- 35 USC 102 Novelty (BERT): 0.5792187961864452
- Combined Prediction Score: 0.716084385995837
- Mean Citation Score: 274.76000400000004
- Max Citation Score: 495.3897
- Similarity Product: 391.1512695228338

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test